CompletedPHASE2, PHASE3NCT05579964

The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot

Studying Tetralogy of Fallot

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Principal Investigator
Dian Kesumarini, MD
National Cardiovascular Center Harapan Kita Hospital Indonesia
Intervention
Dexmedetomidine Hcl 100 Mcg/mL Inj(drug)
Enrollment
66 enrolled
Eligibility
18 years · All sexes
Timeline
20222023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05579964 on ClinicalTrials.gov

Other trials for Tetralogy of Fallot

Additional recruiting or active studies for the same condition.

See all trials for Tetralogy of Fallot

← Back to all trials